<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Research • Stanfield Lab</title>
  <meta name="description" content="Stanfield Lab at LSU SVM: Viral oncology and guinea-pig models of virus-associated cancers.">
  <link rel="icon" href="assets/favicon.svg" type="image/svg+xml">
  <link rel="stylesheet" href="assets/styles.css">
</head>
<body>
  <a class="skip-link" href="#main">Skip to content</a>

<header class="site-header" role="banner">
  <div class="container header-wrap">
    <a class="brand" href="index.html" aria-label="Stanfield Lab home">
      <img src="assets/stanfield-lab-logo.svg" alt="Stanfield Lab" class="brand-img">
    </a>
    <nav aria-label="Primary">
      <button id="navToggle" class="nav-toggle" aria-expanded="false" aria-controls="primaryNav">Menu</button>
      <ul id="primaryNav" class="nav-list">
        <li><a href="index.html">Home</a></li>
        <li><a href="research.html" aria-current="page">Research</a></li>
        <li><a href="people.html">People</a></li>
        <li><a href="publications.html">Publications</a></li>
        <li><a href="news.html">News</a></li>
        <li><a href="opportunities.html">Opportunities</a></li>
        <li><a href="contact.html">Contact</a></li>
      </ul>
    </nav>
    <button id="themeToggle" class="theme-toggle" aria-label="Toggle dark mode">◐</button>
  </div>
</header>

<main id="main" class="container">
  <h1>Research</h1>

  <p>
    The Stanfield Lab investigates how oncogenic herpesviruses initiate infection,
    evade host defenses, and drive cancer development. Our central mission is to
    create and refine <strong>immune-competent guinea pig models</strong> that bridge
    the gap between basic virology and translational medicine. By combining primary
    cell culture, in vivo pathogenesis studies, and advanced genomics, we aim to
    uncover how viruses such as <strong>Kaposi’s sarcoma–associated herpesvirus (KSHV)</strong>
    and <strong>Epstein–Barr virus (EBV)</strong> establish infection and promote tumorigenesis.
  </p>

  <p>
    Guinea pigs provide a uniquely valuable system: their immune and physiological
    responses often parallel those of humans more closely than traditional murine
    models. We leverage this platform to model virus–host interactions, test
    therapeutic strategies, and expand the toolkit for studying host-restricted
    pathogens that have lacked tractable small-animal models.
  </p>

  <h2>Current focus areas</h2>
  <ul class="checklist">
    <li>
      <strong>Innate sensing and viral evasion.</strong>
      Defining how KSHV activates and subverts the <em>IRF7</em>, <em>MDA5</em>, and
      RIG-I pathways in guinea pig cells, and identifying viral genes that interfere
      with these sensors.
    </li>
    <li>
      <strong>Endothelial infection and tumorigenesis.</strong>
      Establishing cultures of guinea pig endothelial cells and modeling how
      KSHV-driven transformation leads to vascularized tumors, both in immunodeficient
      mice and in immunosuppressed strain 2 guinea pigs.
    </li>
    <li>
      <strong>Syngeneic lymphoma model.</strong>
      Characterizing the L2C guinea pig lymphoma line using genomics and single-cell
      RNA sequencing, and positioning it as an analog for human mantle cell lymphoma
      and CLL to test next-generation therapies such as BTK inhibitors.
    </li>
    <li>
      <strong>Comparative virology and viral adaptation.</strong>
      Exploring how related herpesviruses (e.g., rhesus rhadinovirus, guinea pig
      herpes-like viruses) adapt to new hosts, with the goal of engineering
      guinea pig–adapted strains of EBV and KSHV.
    </li>
    <li>
      <strong>Preclinical testing.</strong>
      Using our models to evaluate antivirals, live-attenuated vaccines, and
      epigenetic modulators such as HDAC inhibitors and G-quadruplex stabilizers
      for their ability to alter viral latency, immune responses, and disease
      outcomes.
    </li>
    <li>
      <strong>Single-cell and systems approaches.</strong>
      Applying single-cell RNA sequencing and pathway analysis to dissect how
      infected immune and tumor cell populations respond in vivo, and to map viral
      and host transcriptional programs during infection.
    </li>
  </ul>

  <p>
    Together, these efforts define a comprehensive program in
    <strong>viral oncology</strong>: connecting molecular mechanisms of viral
    pathogenesis to clinically relevant animal models. By expanding the guinea
    pig as a small-animal model, we are working to provide the research
    community with new tools for understanding—and ultimately intervening in—
    virus-associated cancers.
  </p>
</main>

<footer class="site-footer" role="contentinfo">
  <div class="container footer-grid">
    <div class="footer-brand">
      <img src="assets/stanfield-lab-icon.svg" alt="Stanfield Lab icon" class="footer-logo">
      <div>
        <h3>Stanfield Lab</h3>
        <p>Viral Oncology • Small-Animal Models • Translational Immunology</p>
      </div>
    </div>
    <div>
      <h4>Find us</h4>
      <p>
        <a href="https://www.lsu.edu/vetmed/index.php" target="_blank" rel="noopener">LSU School of Veterinary Medicine</a><br>
        Baton Rouge, LA 70803
      </p>
    </div>
    <div>
      <h4>Contact</h4>
      <p><a href="mailto:bstanf5@lsu.edu">bstanf5@lsu.edu</a></p>
    </div>
  </div>
  <div class="container footer-bottom">
    <p>© <span id="year"></span> Stanfield Lab • LSU SVM</p>
  </div>
  <script src="assets/script.js"></script>
</footer>

</body>
</html>
